Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: Results from the NCDR®

Heart Rhythm

Volumn 11, Issue 2, 2014, Pages 216-221

  Kramer, Daniel B ^a,b,c   Kennedy, Kevin F ^d   Spertus, John A ^d   Normand, Sharon Lise ^b,e   Noseworthy, Peter A ^b,f   Buxton, Alfred E ^a,b   Josephson, Mark E ^a,b   Zimetbaum, Peter J ^a,b   Mitchell, Susan L ^a,b,c   Reynolds, Matthew R ^g  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Hebrew SeniorLife Institute for Aging Research   (United States)

^d SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Implantable cardioverter defibrillator; Outcomes research

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SINUS NODE DISEASE; SUDDEN CARDIAC DEATH; SURVIVAL;

AGED; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 84893688475     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.10.046     Document Type: Article

References (21)

1. S.H. Hohnloser, and C.W. Israel Current evidence base for use of the implantable cardioverter-defibrillator Circulation 128 2013 172 183
2. A.M. Russo, R.F. Stainback, and S.R. Bailey et al. ACCF/HRS/AHA/ASE/HFSA/ SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J Am Coll Cardiol 61 2013 1318 1368
3. A.E. Buxton, K.L. Lee, and G.E. Hafley et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157
4. I. Goldenberg, A.K. Vyas, and W.J. Hall et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
5. K.C. Bilchick, G.J. Stukenborg, S. Kamath, and A. Cheng Prediction of mortality in clinical practice for Medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death J Am Coll Cardiol 60 2012 1647 1655
6. D.B. Kramer, P.A. Friedman, and L.M. Kallinen et al. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators Heart Rhythm 9 2012 42 46
7. R. Parkash, W.G. Stevenson, L.M. Epstein, and W.H. Maisel Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection Am Heart J 151 2006 397 403
8. M.S. Kremers, S.C. Hammill, and C.I. Berul et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011 Heart Rhythm 10 2013 e59 e65
9. D.B. Kramer, K.F. Kennedy, and P.A. Noseworthy et al. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR Circ Cardiovasc Qual Outcomes 6 2013 488 497
10. D.B. Kramer, A.E. Buxton, and P.J. Zimetbaum Time for a change: a new approach to ICD replacement N Engl J Med 366 2012 291 293
11. S.C. Hammill, M.S. Kremers, and L.W. Stevenson et al. Review of the Registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure Heart Rhythm 7 2010 1340 1345
12. S.M. Al-Khatib, A. Hellkamp, and J. Curtis et al. Non-evidence-based ICD implantations in the United States JAMA 305 2011 43 49
13. S.M. Al-Khatib, A. Hellkamp, and G.H. Bardy et al. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials JAMA 309 2013 55 62
14. National Cardiovascular Data Registry-ICD Registry website. Available at https://www.ncdr.com/webncdr/icd/home/datacollection. Accessed July 31, 2012.
15. A.S. Fein, Y. Wang, J.P. Curtis, F.A. Masoudi, P.D. Varosy, and M.R. Reynolds Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry J Am Coll Cardiol 56 2010 766 773
16. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
17. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 1999 461 470
18. D.S. Lee, J.V. Tu, and P.C. Austin et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation J Am Coll Cardiol 49 2007 2408 2415
19. K.M. Stein, S. Mittal, and F.R. Gilliam et al. Predictors of early mortality in implantable cardioverter-defibrillator recipients Europace 11 2009 734 740
20. A. Barsheshet, A.J. Moss, D.T. Huang, S. McNitt, W. Zareba, and I. Goldenberg Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator J Am Coll Cardiol 59 2012 2075 2079
21. W.C. Levy, K.L. Lee, and A.S. Hellkamp et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842